Trial NCT05487040

View at ClinicalTrials.gov 
Org. Study IDs: C4671028
Secondary IDs: EPIC-SRI

Last trial update was posted on 2023-12-07

MeSH Interventions

Nirmatrelvir Ritonavir

MeSH Conditions

COVID-19

Other Conditions


Stopping Reasons

Decision to terminate study was due to slow enrolment and FDA input that available data may be enough for dosing recommendations for severe renal disease (subject to review by FDA).

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID